This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2010 Feb;57(2):358.

doi: 10.1016/j.eururo.2009.11.021.

Words of wisdom. Re: XMRV is present in malignant prostate epithelium and is associated with prostate cancer, especially high-grade tumors

Greg Trottier¹, Neil E Fleshner

Affiliations

PMID: 20116772
DOI: 10.1016/j.eururo.2009.11.021

Comment

Words of wisdom. Re: XMRV is present in malignant prostate epithelium and is associated with prostate cancer, especially high-grade tumors

Greg Trottier et al. Eur Urol. 2010 Feb.

. 2010 Feb;57(2):358.

doi: 10.1016/j.eururo.2009.11.021.

Authors

Greg Trottier¹, Neil E Fleshner

Affiliation

¹ Division of Urology, Department of Surgical Oncology, Princess Margaret Hospital, University Health Network, University of Toronto, Toronto, Canada.

PMID: 20116772
DOI: 10.1016/j.eururo.2009.11.021

No abstract available

PubMed Disclaimer

Comment on

XMRV is present in malignant prostatic epithelium and is associated with prostate cancer, especially high-grade tumors.
Schlaberg R, Choe DJ, Brown KR, Thaker HM, Singh IR. Schlaberg R, et al. Proc Natl Acad Sci U S A. 2009 Sep 22;106(38):16351-6. doi: 10.1073/pnas.0906922106. Epub 2009 Sep 8. Proc Natl Acad Sci U S A. 2009. Retraction in: Proc Natl Acad Sci U S A. 2014 Aug 19;111(33):12270. doi: 10.1073/pnas.1409186111. PMID: 19805305 Free PMC article. Retracted.

Publication types

Actions

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science
Research Materials
- NCI CPTC Antibody Characterization Program